Gilead's Manufacturing Practices Face Renewed Scrutiny With DoJ Investigation
This article was originally published in The Pink Sheet Daily
Executive Summary
Subpoenas seeking documents related to the manufacture, quality and distribution practices for six marketed products come less than a year after an FDA warning letter cited deficiencies at the company's California manufacturing and packaging facility, although it's unclear whether the two events are related.